छोड़कर सामग्री पर जाएँ

Latest News

RBI makes no change to FY24 inflation forecast, implies sub-5% CPI in September

RBI makes no change to FY24 inflation forecast, implies sub-5% CPI in September

RBI Monetary Policy: Headline retail inflation has averaged 7.1 percent in July-August, well above the upper bound of the central bank#39;s tolerance range of 2-6 percent Read More ​ RBI Monetary Policy: Headline retail inflation has averaged 7.1 percent in July-August,… और पढ़ें »RBI makes no change to FY24 inflation forecast, implies sub-5% CPI in September

Emerging economies face China and rate pressures as IMF, World Bank meet

Emerging economies face China and rate pressures as IMF, World Bank meet

Restructuring efforts for defaulted countries could reach a breakthrough before year-end as talks continue, while the finances of nations like Pakistan and Egypt will also be under scrutiny when policy makers and asset managers gather for the World Bank and… और पढ़ें »Emerging economies face China and rate pressures as IMF, World Bank meet

India among top 3 nations with highest 5G base, roll-out remarkable: Nokia CEO Pekka Lundmark

India among top 3 nations with highest 5G base, roll-out remarkable: Nokia CEO Pekka Lundmark

Nokia President and CEO Pekka Lundmark was addressing an event during the inauguration of the company#39;s 6G research lab in Bengaluru on Thursday. “5G roll-out in India is truly remarkable. Read More ​ Nokia President and CEO Pekka Lundmark was addressing… और पढ़ें »India among top 3 nations with highest 5G base, roll-out remarkable: Nokia CEO Pekka Lundmark

Strides Pharma Science shares worth Rs 69 crore exchange hands; stock falls over 1.5%

Strides Pharma Science shares worth Rs 69 crore exchange hands; stock falls over 1.5%

13.75 lakh shares of Strides Pharma Sciences changed hands, following which, the stock price sank over 1.5 percent Read More ​ 13.75 lakh shares of Strides Pharma Sciences changed hands, following which, the stock price sank over 1.5 percent 13.75 lakh… और पढ़ें »Strides Pharma Science shares worth Rs 69 crore exchange hands; stock falls over 1.5%

Valiant Laboratories lists at Rs 162, a 16% premium to IPO price

Valiant Laboratories lists at Rs 162, a 16% premium to IPO price

Valiant Laboratories is an active pharmaceutical ingredient and bulk drug manufacturing company with focus on manufacturing of paracetamol Read More ​ Valiant Laboratories is an active pharmaceutical ingredient and bulk drug manufacturing company with focus on manufacturing of paracetamol Valiant Laboratories… और पढ़ें »Valiant Laboratories lists at Rs 162, a 16% premium to IPO price

hi_INहिन्दी